Learn more by exploring our library of videos, webinars, publications and more.

Our enrollment of the 100th patient in the ROADS GammaTile® Clinical Trial marks a pivotal moment. This trial focuses on newly diagnosed metastatic brain tumors.

GT Medical Technologies’ new CEO, Per Langoe, was interviewed by MedTech Dive about his plans to partner with healthcare providers and drive the adoption of GammaTile®, the only FDA-cleared revolutionary innovation in brain brachytherapy.

Vice President of Marketing, Jane Steen, shared thought-provoking insights in an interview discussing the dynamic evolution of point-of-care marketing. Explore the key highlights here.

Facing glioblastoma, Gilbert Stuart found hope with GammaTile introduced by Dartmouth Hitchcock Medical Center

Opinion Piece:
Yes. Brachytherapy for the treatment of intracranial malignancies holds tremendous promise for optimal management of these frequently complex patients. – Drs. Weinberg and Beckham
No. The role of brachytherapy for malignant gliomas has been well investigated and found to confer no survival benefit for patients when combined with best surgical resection and standard external radiotherapy. – Dr. Barnett

Dr. Kotecha: Radiation therapy can be delivered to the brain externally through machines, which is called external beam radiation therapy. This is the most common approach or use in radiation therapy and some terms that you may hear that are using this type of treatment are stereotactic radiosurgery. An alternative means of delivering radiation therapy is when radiation is actually implanted into the brain itself, and that is called brachytherapy.

Neuro-Oncology Advances 2021 | Dominic J Gessler, Elizabeth C Neil, Rena Shah, Joseph Levine, James Shanks, Christopher Wilke, Margaret Reynolds, Shunqing Zhang, Can Özütemiz, Mehmet Gencturk, Mark Folkertsma, W Robert Bell, Liam Chen, Clara Ferreira, Kathryn Dusenbery, Clark C Chen. GammaTile® Brachytherapy in the Treatment of Recurrent Glioblastomas [published online December 27, 2021]. https://doi.org/10.1093/noajnl/vdab185

During these uncertain times, remember to proactively reach out to patients and encourage them to resume routine cancer screenings to prevent delayed diagnoses that might lead to worsened health outcomes.

Matt Likens describes GammaTile Therapy, GT Medical Technologies’ mission, and how working with Silicon Valley Bank has helped GT Medical achieve their purpose of improving the lives of patients with brain tumors.

Orange Park Medical Center is the first hospital in North Florida to provide a new brain tumor treatment the size of a computer chip.